HomeNewsBusinessEarningsParabolic Drugs standalone Dec '13 sales at Rs 114.42 crore

Parabolic Drugs standalone Dec '13 sales at Rs 114.42 crore

Parabolic Drugs has reported a standalone sales turnover of Rs 114.42 crore and a net loss of Rs 24.46 crore for the quarter ended Dec '13

February 17, 2014 / 16:22 IST
Story continues below Advertisement

Parabolic Drugs has reported a standalone sales turnover of Rs 114.42 crore and a net loss of Rs 24.46 crore for the quarter ended Dec '13.
For the quarter ended Dec 2012 the standalone sales turnover was Rs 152.24 crore and net loss was Rs 25.59 crore.
Parabolic Drugs shares closed at 5.90 on February 14, 2014 (NSE) and has given 49.37% returns over the last 6 months and -34.81% over the last 12 months.
Parabolic Drugs
Standalone Quarterly Results-------- in Rs. Cr. --------
Dec '13Sep '13Jun '13
Sales Turnover114.42117.1299.48
Other Income------
Total Income114.42117.1299.48
Total Expenses112.86112.8597.09
Operating Profit1.564.272.39
Profit On Sale Of Assets------
Profit On Sale Of Investments------
Gain/Loss On Foreign Exchange------
VRS Adjustment------
Other Extraordinary Income/Expenses------
Total Extraordinary Income/Expenses----10.70
Tax On Extraordinary Items------
Net Extra Ordinary Income/Expenses------
Gross Profit1.564.272.39
Interest19.9319.5920.00
PBDT-18.37-15.32-6.91
Depreciation17.0316.9917.04
Depreciation On Revaluation Of Assets------
PBT-35.40-32.31-23.95
Tax-10.94-9.99--
Net Profit-24.46-22.32-23.95
Prior Years Income/Expenses------
Depreciation for Previous Years Written Back/ Provided------
Dividend------
Dividend Tax------
Dividend (%)------
Earnings Per Share------
Book Value------
Equity61.8961.8961.89
Reserves------
Face Value10.0010.0010.00
Source : Dion Global Solutions Limited
first published: Feb 17, 2014 04:22 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!